Since July 2020, remdesivir has been conditionally approved in Europe for the treatment of coronavirus disease (COVID-19) in adults and adolescents aged 12 years and older with pneumonia who require supplemental oxygen but no invasive ventilation. In an early benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG) has now investigated […]
Parental COVID-19 vaccine hesitancy may be next challenge for vaccination campaigns
The development of several new mRNA and viral vector vaccines in the space of a single year has changed how we understand vaccine hesitancy. As a gender and social justice researcher in the health humanities, I began tracking COVID-19 vaccine hesitancy in the spring of 2020. My research assistant and I analyzed debates as they […]
Study shows low COVID-19 infection rate in health care workers
Antibody testing of health care workers in three rural counties in eastern South Dakota and western Minnesota showed 15% of the study participants had antibodies to the novel coronavirus. “Antibodies (to the novel coronavirus) show the true prevalence (of COVID-19) in the population,” according to South Dakota State University assistant professor Natalie Thiex, whose research […]
Coronavac COVID-19 vaccine safe in children and adolescents and triggers antibodies
Two doses of CoronaVac are safe and provoke a strong antibody response among children and adolescents aged 3-17 years, according to a randomised controlled trial of 550 young people published in The Lancet Infectious Diseases journal. More than 96% of children and adolescents who received two doses of the vaccine—manufactured by Sinovac—developed antibodies against SARS-CoV-2. […]
Is the Delta Plus COVID-19 variant a new concern?
India, already hit hard by the Delta variant of COVID-19, has labeled a closely related new variant—dubbed “Delta Plus”—as a “variant of concern.” But some epidemiologists in India and abroad say there is not enough data yet to warrant broader cautions about the variant, CBS News reported. Delta Plus cases are rising in India, and […]
Celltrion Says Trial Shows Antibody COVID-19 Treatment to Be Safe and Effective
SEOUL (Reuters) – South Korean drugmaker Celltrion Inc on Monday announced positive results for its experimental antibody COVID-19 treatment that it said was safe and reduced the treatment period by nearly five days in Phase 3 global clinical trials. The trials, which involved 1,315 participants, have taken place since January in 13 countries, including in […]
Fauci warns Indian COVID-19 variant could become dominant in the US
Fauci says Indian COVID-19 variant makes up 6% of all cases in the US and could become the dominant strain if Americans don’t get vaccinated The Indian variant known as B.1.617.2 currently makes up 6% of all coronavirus cases sequenced in the U.S. Indian authorities have referred to it as a ‘double mutant’ because it […]
Indian City’s Death Data Suggests Official Tally of COVID Fatalities Is Too Low
SURAT, India (Reuters) – At least seven crematoriums and graveyards in India’s western city of Surat saw a more than three-fold rise in the number of cremations and burials last month compared with a year ago, suggesting many more COVID-19 fatalities than an official tally. The data, gathered from site visits and logs reviewed by […]
Immunity after COVID-19 illness may last at least 1 year
Long-term data from northern Italy—an area hit hard during the early days of the pandemic—suggests that reinfection after recovery from COVID-19 infection is very rare, and immunity in former patients could be long-lasting. “Natural immunity to SARS-CoV-2 appears to confer a protective effect for at least a year, which is similar to the protection reported […]
How to increase COVID-19 vaccine uptake in young people
Ending the coronavirus pandemic rests partly on a large uptake of COVID-19 vaccines, with the goal of reaching herd immunity. Recently in Canada, the age for vaccine eligibility has been decreasing to include young adults and adolescents. However, little work has been done to understand willingness to receive the vaccine among this age group. Our […]